Compare NEXT & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEXT | GRDN |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | 3600 |
| Industry | Oil & Gas Production | Retail-Drug Stores and Proprietary Stores |
| Sector | Energy | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2014 | N/A |
| Metric | NEXT | GRDN |
|---|---|---|
| Price | $8.51 | $40.43 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $8.00 | ★ $40.60 |
| AVG Volume (30 Days) | ★ 2.6M | 388.7K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.63 |
| P/E Ratio | ★ N/A | $117.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.75 | $19.17 |
| 52 Week High | $12.12 | $41.36 |
| Indicator | NEXT | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 54.49 | 65.65 |
| Support Level | $4.89 | $31.74 |
| Resistance Level | $8.54 | $41.36 |
| Average True Range (ATR) | 0.39 | 1.60 |
| MACD | -0.03 | 0.29 |
| Stochastic Oscillator | 48.09 | 77.96 |
NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas, the sale of LNG, and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions, advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.